Drugs / DDFPe
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02963376 Comparator | Feb 2017 → Jul 2018 | ischemic stroke | NuvOx LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DDFPe | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02963376 ↗ |
| Known as | Dodecafluoropentane emulsion (DDFPe), NanO2TM | “Dodecafluoropentane emulsion (DDFPe), NanO2TM” NCT02963376 ↗ |
| Route | Intravenous | “intravenous administration of DDFPe” NCT02963376 ↗ |